Related Experiment Video
Updated: Jan 3, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.1K
Pharmaceutical Aspects of Artificial Nutrition
Emilie Reber1, Markus Messerli2, Zeno Stanga1
1Department for Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Bern University Hospital and University of Bern, 3010 Bern, Switzerland.
Journal of Clinical Medicine
|November 23, 2019
Summary
Artificial nutrition, including enteral (EN) and parenteral (PN) nutrition, provides essential nutrients when oral intake is insufficient. Careful pharmaceutical management is crucial to ensure safety and efficacy, preventing serious complications.
Area of Science:
- Clinical Nutrition
- Pharmaceutical Sciences
- Patient Care
Background:
- Artificial nutrition (enteral and parenteral) is vital when oral intake is inadequate.
- Parenteral nutrition (PN) requires central venous access and is complex to prepare and administer.
- Both EN and PN can lead to severe complications if not handled correctly.
Purpose of the Study:
- To review the current state of artificial nutrition.
- To highlight pharmaceutical challenges in PN, including stability and drug interactions.
- To emphasize the importance of individualized nutrition and medication regimens.
Main Methods:
- This is a narrative review.
- It synthesizes current knowledge on artificial nutrition.
- Focuses on pharmaceutical aspects of PN.
Main Results:
- PN admixtures have limited stability and are generally unsuitable as drug vehicles.
- Incorrect handling of PN can cause severe complications like sepsis or metabolic intolerance.
- Expertise in compatibility and stability testing is essential for safe PN formulation.
Conclusions:
- Optimal artificial nutrition requires meticulous attention to pharmaceutical details.
- Individualized regimens and careful monitoring are critical for patient safety and treatment efficacy.
- Understanding instabilities, incompatibilities, and drug interactions is key to best practice.
Related Concept Videos
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
728
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
728
01:26Enteral Nutrition I: Orogastric and Nasogastric Feeding
1.1K
Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
1.1K
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
183
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
183
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
660
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
660
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
01:26Drug Administration and Therapy Phases: Overview
1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K